Delivery Order SPE2DX15D9223-SPE2DX23FUKEF

Award Date 9/25/23
Potential Completion Date 10/17/23
Potential Value $9.3K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price delivery order was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,094.80, is for the supply of Xolair 150 mg/ml syringes. This order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which covers a wide...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The $30,948.00 contract is for the delivery of 150 mg/mL syringes of the biologic Xolair to fulfill the recurring pharmaceutical supply needs of military health facilities. The delivery order was issued under DMS Pharmaceutical Group's $499,999,999 single-award indefinite delivery contract with the DLA, which...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $21,663.60, is for the delivery of Xolair 150 mg/ml syringes and has an ultimate completion date of July 17, 2024. This delivery order is placed under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows the...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth up to $5,415.90 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of Xolair 150 mg/mL syringes. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which runs through December 31, 2025. The IDC allows the DLA...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth up to $3,094.80 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of Xolair 150 mg/mL syringes, with a period of performance through April 18, 2024. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract, number SPE2DB, valued at up to $4,999,999 through the end of 2025, which allows DLA to issue firm fixed-price...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $92,844.00, is to provide Xolair 150 mg/mL syringes to support the recurring medical supply needs of military health facilities. This delivery order is issued under DMS Pharmaceutical Group's existing $499,999,999 indefinite delivery contract (IDC) with the DLA,...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $1,547.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Xolair 150 mg/mL syringes to support the medical supply needs of military health facilities. This delivery order is part of a larger $499,999,999 indefinite-delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,284.40 firm fixed-price contract is for the delivery of Xolair 150 mg/mL syringes to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999 that...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,284.40 contract is for the supply of Xolair 150 mg/mL syringes, a specialty medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC allows the...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $18,568.80, is for the delivery of Xolair 150 mg/mL syringes to support the medical supply needs of military health facilities. This order is placed under DMS Pharmaceutical Group's larger indefinite-delivery contract (IDC) with the DLA, valued at up to...
  • SPE2DX15D9223
    Indefinite Delivery Contract
  • SPE2DX15D9223-SPE2DX23FUKEF
    Delivery Order

This firm-fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract has a ceiling value of $9,284.40 and is set to expire on October 17, 2023.

The contract provides for the delivery of 150 mg/mL syringes of the pharmaceutical product Xolair to fulfill the recurring medical supply needs of military health facilities supported by DLA worldwide. This delivery order is issued under DMS Pharmaceutical Group's larger $4,999,999 indefinite delivery contract with DLA, which enables the agency to place firm-fixed-price orders for a broad range of pharmaceutical items to support the Department of Defense.

Generated 6/14/24, 9:08 AM